Insulin resistance is a risk factor for the progression of chronic kidney disease

Clinical Nephrology

Volumn 71, Issue 6, 2009, Pages 643-651

  Kobayashi, H ^a   Tokudome, G ^a   Hara, Y ^a   Sugano, N ^a   Endo, S ^a   Suetsugu, Y ^a   Kuriyama, S ^b   Hosoya, T ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

Author keywords

CKD; HOMA R; Hypertension; Insulin resistance; Renal dysfunction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; TRIACYLGLYCEROL; INSULIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FUNCTION; LINEAR REGRESSION ANALYSIS; MALE; PATHOGENESIS; PLASMA RENIN ACTIVITY; RISK FACTOR; BLOOD; CHRONIC KIDNEY FAILURE; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; URINE;

CREATININE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 67651037293     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71643     Document Type: Article

References (34)

1. Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med. 1998; 15: 539-553.
2. 1 and matrix mRNAs in mesangeal cells. Kidney Int. 1996; 50: 745-753.
3. Bringgs JP, Schnermann J. The tubular glomerular feedback mechanism: function and biochemical aspects. Annu Rev Physiol. 1987; 49: 251-273.
4. Chen J, Muntner P, Hamm L, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004; 140: 167-174.
5. Cohen AJ, McCarty DM, Stoff JS. Direct hemodynamic effect of insulin in the isolated perfused kidney. Am J Physiol. 1989; 257: F580-F585.
6. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001; 86: 3574-3578.
7. Fliser D, Pacini G, Engelleiter R, Kauzly-Willer A, Prager R, Frank E, Ritz E. Insulin resistance and hyperlipemia are already present in patients with incipient renal disease. Kidney Int. 1998; 53: 1343-1347.
8. Fukui M, Nakamura t, Ebihara I, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H. Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med. 1993; 122: 149-156.
9. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1305.
10. Henriksen EJ, Jacob S, Kinnick T, Teachey K, Krekler M. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension. 2001; 38: 884-890.
11. Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, MaClellan WM. Association of the insulin resistance syndrome and microalbuminuria among non-diabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol. 2002; 13: 1626-1634.
12. Kanauchi M, Yamano S, Kanauchi K, Saito Y. Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in non-obese, non-diabetic subjects with high-normal blood pressure. J Clin Endocrinol Metab. 2003; 88: 3444-3446.
13. Kato Y, Hayashi M, Ohno Y, Suzawa T, Sasaki T, Saruta T. Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. Clin Nephrol. 2000; 54: 366-373.
14. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama Study. Stroke. 2003; 34: 2349-2354.
15. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005; 16: 2134-2140.
16. Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreas G, Gassman J, Lash J, Miller ER 3rd, Randall O, Wang X, McClellan W, AASK study Investigators. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African American. Am J Kidney Dis. 2008; 51: 732-740.
17. Manjunath G, Tighiouart H, Ibarahim H, Aceod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak M. Level of kidney function as a rick factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003; 41: 47-55.
18. Mohteshamzadeh M, Wong C, Whiticar R, Thomas S. Is there a link between insulin resistance and chronic kidney disease in men with treated hypertension? Analysis of 5-year data. Am J Nephrol. 2008; 29: 116-122.
19. Muscelli E, Natali A, Bianchi D, Bigazzi R, Galvan AQ, Siron AM, Fracerra S, Cioiaro D, Ferrannini E. Effect of insulin on renal sodium and uric acid. Am J Hypertens. 1996; 9: 746-752.
20. Nagel JM, Tietz AB, Goke B, Parhofer KG. The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin resistant subjects. Metab Clin Exp. 2006; 55: 1149-1154.
21. Nakanishi N, Takatorige T, Fukuda H, Shirai K, Li W, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Components of the metabolic syndrome as predictors of cardiovascular disease and Type 2 diabetes in middle-aged Japanese men. Diabet Res Clin Pract. 2004; 64: 59-70.
22. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, Classification, and Stratification. Am J Kidney Dis. 2002; 39 (Suppl. 1): S1-S266.
23. Ninomiya T, Kiyohara K, Kubo N, Yonemoto K, Tanizaki Y, Doi Y, Hirakata H, Iida M. Metabolic syndrome and CKD in a general Japanese population: The Hisayama Study. Am J Kidney Dis. 2006; 48: 383-391.
24. Ninomiya T, Kiyohara K, Kubo N, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M. Chronic kidney disease and cardiovascular disease in a general Japanese population. Kidney Int. 2005; 68: 228-236.
25. Obrador GT, Pereira BJ, Kausz AT. Chronic kidney disease in the United States: An underrecognized problem. Sem Nephrol. 2002; 22: 441-448.
26. Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DL. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension. 1990; 15: 861-865.
27. Scherrer U, Randin D, Tian J, Vollenweider P, Vollenweider L, Nicod P. Nitric oxides release accounts for insulin's vascular effects in human. J Clin Invest. 1994; 98: 2511-2515.
28. Seo H-S, Kang TS, Park S, Park H-Y, Ko Y-G, Choi D, Jang Y, Chung N. Insulin resistance is associated with arterial stiffness in nondiabetic hypertensives independent of metabolic status. Hypertens Res. 2005; 28(12): 945-951.
29. Shiuchi T, Iwai M, Li T-X, Wu L, Min L-J, Li J-M, Okumura M, Cui T-X, Horiuchi M. Angiotensin II Type 1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscle of diabetic mice. Hypertension. 2004; 43: 1003-1010.
30. Steinber HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: implication for the syndrome of insulin resistance. J Clin Invest. 1996; 97: 2601-2610.
31. Tanaka H, Shiohira Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006; 69: 369-374.
32. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26: 3160-3167.
33. Tucker BJ, Anderson CM, Thies RS, Collins RC, Blantz RC. Glomerular hemodynamic alterlations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int. 1992; 42: 1160-1168.
34. Vedovato M, Lepore G, Coracina A, Dodesini AR, Jori E, Tiengo A, Del Plrato S, Trevisian R. Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance. Diabetologia. 2004; 47: 300-303.